Ciprofloxacin-induced urticaria and tenosynovitis: A case report

dc.authoridmemişoğlu, funda/0000-0003-3905-1182
dc.authoridBayindir, Yasar/0000-0003-3930-774X
dc.authoridKayabas, Uner/0000-0002-5323-0796
dc.authorwosidmemişoğlu, funda/AAA-4392-2021
dc.authorwosidOzcan, Hamdi/T-8408-2019
dc.authorwosidBayindir, Yasar/T-1523-2017
dc.authorwosidKayabas, Uner/JRX-1616-2023
dc.contributor.authorKayabas, Uner
dc.contributor.authorYetkin, Funda
dc.contributor.authorFirat, Ahmet K.
dc.contributor.authorOzcan, Hamdi
dc.contributor.authorBayindir, Yasar
dc.date.accessioned2024-08-04T20:30:56Z
dc.date.available2024-08-04T20:30:56Z
dc.date.issued2008
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: Tendon disorders are rare events associated with fluoroquinolone congestion. Skin reactions are more frequent than tendon disorders. We reported this case as the combination of ciprofloxacin-induced urticaria and tenosynovitis has been unreported in young women. Case: A 28-year-old woman without underlying disease developed urticarias and tendinopathy 4 days after the initiation of ciprofloxacin treatment for urinary infection. MRI of the left foot revealed increased synovial fluid surrounding the tendon of the flexor hallucis longus muscle representing tenosynovitis. Ciprofloxacin was ceased due to the possibility of ciprofloxacin-induced tendinopathy and urticaria. Complete resolution of her symptoms and findings occurred 3 days after discontinuation of ciprofloxacin without any additional treatment. Conclusion: Early discontinuation of fluoroquinolone therapy when tendinopathy is suspected is the basis of therapy. So, it should be kept in mind that fluoroquinolone-induced tendinopathy may occur in an otherwise healthy young patient with no risk factors and in a site other than the Achilles tendon. Copyright (C) 2008 S. Karger AG, Basel.en_US
dc.identifier.doi10.1159/000149720
dc.identifier.endpage290en_US
dc.identifier.issn0009-3157
dc.identifier.issn1421-9794
dc.identifier.issue4en_US
dc.identifier.pmid18667819en_US
dc.identifier.scopus2-s2.0-48049114408en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage288en_US
dc.identifier.urihttps://doi.org/10.1159/000149720
dc.identifier.urihttps://hdl.handle.net/11616/94602
dc.identifier.volume54en_US
dc.identifier.wosWOS:000258929200006en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofChemotherapyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjecttenosynovitisen_US
dc.subjectciprofloxacinen_US
dc.subjectadverse drug reactionen_US
dc.subjecttendinopathyen_US
dc.subjecturticariaen_US
dc.subjectskin reactionen_US
dc.subjectfluoroquinoloneen_US
dc.titleCiprofloxacin-induced urticaria and tenosynovitis: A case reporten_US
dc.typeArticleen_US

Dosyalar